Commodore Capital LP - 30 Sep 2025 SCHEDULE 13G/A Report for Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (TERN)

Filing Manager
Commodore Capital LP
Reporting Manager
Commodore Capital LP
Security
Terns Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share
Symbol
TERN
Shares outstanding
87,692,308 shares
Disclosed Ownership
5,700,000 shares
Ownership
6.5%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 16:51:37 UTC
Date of event
30 Sep 2025
Previous filing
16 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Commodore Capital LP 6.5% 5,700,000 0 5,700,000 Michael Kramarz Managing Partner
Commodore Capital Master LP 6.5% 5,700,000 0 5,700,000 Michael Kramarz Managing Partner
Robert Egen Atkinson 6.5% 5,700,000 0 5,700,000 Robert Egen Atkinson Authorized Signatory
Michael Kramarz 6.5% 5,700,000 0 5,700,000 Michael Kramarz Authorized Signatory